HeyJaredMelina Khan
- Indexed articles, last 90 days
- 37
- Latest publication
- Sep 29, 2026
- Outlet visibility, for Yahoo
- Top 1K sites
- Earliest in this view
- Jul 6, 2026
Latest articles
Dunkin’, L.L. Bean Launch Merch Collab with Free Coffee Giveaway (opens the original)
Read excerpt
Two New England-based brands are teaming up for fall and National Coffee Day. Dunkin’ and L.L.Bean have collaborated for the first time, launching merchandise and freebie offers that culminate in a free coffee giveaway Tuesday, Sept. 29. The companies began promoting the collaboration with a coffee koozie giveaway on Sept. 22. The mini-sweater-shaped koozies quickly ran out at participating Dunkin’ locations nationwide. The brands’ merchandise collection, launching Sept. 29, includes a coffee ac
E. coli outbreak linked to raw cheese. See recalled products - AOL (opens the original)
Read excerpt
Public health officials are investigating an outbreak of E. coli infections linked to raw milk cheese products, which have now been recalled. Thirteen people in nine states have been sickened with E. coli infections in the outbreak, according to Sept. 25 notices from the Centers for Disease Control and Prevention and Food and Drug Administration. Everyone who has been interviewed so far reported consuming Sierra Nevada Graziers raw milk cheese before falling sick, according to the FDA. Sierra Ne
CVS Customers May Be Eligible for Money From Settlement (opens the original)
Read excerpt
Many CVS customers may be eligible for up to $10 from a settlement in a class action lawsuit over the sharing of website and app user data with advertising company Criteo. CVS and Criteo denied wrongdoing. CVS said the settlement avoids the expense and distraction of prolonged litigation. Anyone who accessed cvs.com, cvshealth.com or the CVS mobile app in the United States before July 27 may be eligible for the settlement class, according to the settlement website. Eligible customers can submit
Thyroid medicine recall receives FDA's highest risk level - AOL (opens the original)
Read excerpt
Officials have classified the risk level of a thyroid medicine recall initiated last month to its most serious category. On Sept. 22, the U.S. Food and Drug Administration categorized the recall – which applies to one lot of thyroid tablets sold by Vitruvias Therapeutics Inc. – as a Class I recall, its highest risk level. Last month, Vitruvias Therapeutics Inc. recalled one lot of its 30 mg thyroid tablets because they could be superpotent, or stronger than intended, according to a FDA recall no
Thyroid Medicine Recall Receives FDA’s Highest Risk Level (opens the original)
Read excerpt
Officials have classified the risk level of a thyroid medicine recall initiated last month to its most serious category. On Sept. 22, the U.S. Food and Drug Administration categorized the recall, which applies to one lot of thyroid tablets sold by Vitruvias Therapeutics Inc., as a Class I recall, its highest risk level. Last month, Vitruvias recalled one lot of its 30 mg thyroid tablets because they could be superpotent, or stronger than intended, according to an FDA recall notice published Aug.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1K sites
For Yahoo, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.